A novel mechanism of resistance to mouse mammary tumor virus infection

Journal of Virology

Volumn 74, Issue 6, 2000, Pages 2752-2759

  Golovkina, Tatyana V ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; DISEASE PREDISPOSITION; FEMALE; LYMPHOCYTE; MAMMARY GLAND; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR RESISTANCE; VIRUS INFECTION; VIRUS PATHOGENESIS;

ANIMALS; ANIMALS, NEWBORN; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHROMOSOME MAPPING; DNA, VIRAL; FEMALE; GENES, RECESSIVE; IMMUNITY, NATURAL; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED C3H; MICE, NEUROLOGIC MUTANTS; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS; VIRUS SHEDDING;

EID: 0342470617     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.6.2752-2759.2000     Document Type: Article

References (43)

1. Acha-Orbea, H., A. N. Shakhov, L. Scarpellino, E. Kolb, V. Muller, A. Vessaz Shaw, R. Fuchs, K. Blochlinger, P. Rollini, J. Billotte, M. Sarafidou, H. R. MacDonald, and H. Diggelmann. 1991. Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus. Nature 350:207-211.
2. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
3. Altrock, B. W., R. D. Cardiff, and P. B. Blair. 1981. Murine mammary tumor virus seroepidemiology in BALB/cfC3H mice: correlation with tumor development. JNCI 67:163-168.
4. Andervont, H., and H. Stewart. 1937. Adenomatous lesion in the stomach of strain I mice. Science 86:566-567.
5. Andervont, H. B. 1964. Fate of the C3H mammary tumor agent in mice of strains C57BL, I, and BALB/c. J. Natl. Cancer Inst. 32:1189-1198.
6. Andervont, H. B. 1940. Further studies on the susceptibility of hybrid mice to induced and spontaneous tumors. J. Natl. Cancer Inst. 1:135-145.
7. Andervont, H. B. 1940. The influence of foster nursing upon the incidence of spontaneous mammary cancer in resistant and susceptible mice. J. Natl. Cancer Inst. 1:147-153.
8. Andervont, H. B. 1943. Influence of hybridization upon the occurrence of mammary tumors in mice. J. Natl. Cancer Inst. 3:359-365.
9. Andervont, H. B. 1937. The use of pure strain animals in studies on natural resistance to transplantable tumors. Public Health Rep. 52:1885-1895.
10. bq genes. Implications for the origin of MHC polymorphism. J. Immunol. 144:1957-1964.
11. Beutner, U., E. Kraus, D. Kitamura, K. Rajewsky, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens, J. Exp. Med. 179:1457-1466.
12. Bittner, J. J. 1958. Genetic concepts in mammary cancer in mice. Ann. N. Y. Acad. Sci. 71:943-975.
13. Brandt-Carlson, C., J. S. Butel, and D. Wheeler. 1993. Phylogenetic and structural analysis of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology 185:171-185.
14. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60-66.
15. Choi, Y., J. W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of the mouse mammary tumor virus. Nature 350:203-207.
16. Coffin, J. M. 1996. Retroviridae: the viruses and their replication, 3rd ed. Raven Press, New York, N.Y.
17. Dembic, Z., M. Ayane, J. Klein, M. Steinmetz, C. O. Benoist, and D. J. Mathis. 1985. Inbred and wild mice carry identical deletions in their E alpha MHC genes. EMBO J. 4:127-131.
18. Dux, A., and P. Demant. 1987. MHC-controlled susceptibility to C3H-MTV-induced mouse mammary tumors is predominantly systemic rather than local. Int. J. Cancer 40:372-377.
19. Dzuris, J., T. V. Golovkina, and S. R. Ross. 1997. Both T and B cells shed infectious mouse mammary tumor virus. J. Virol. 71:6044-6048.
20. Frankel, W. N., C. Rudy, J. M. Coffin, and B. T. Huber. 1991. Linkage of MIs genes to endogenous mammary tumour viruses of inbred mice. Nature 349: 526-528.
21. Golovkina, T., J. Prescott, and S. Ross. 1993. Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection. J. Virol. 67:7690-7694.
22. Golovkina, T. V., A. Chervonsky, J. A. Prescott, C. A. Janeway, and S. R. Ross. 1994. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J. Exp. Med. 179:439-446.
23. Golovkina, T. V., A. V. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637-645.
24. Golovkina, T. V., J. P. Dudley, and S. R. Ross. 1998. B and T cells are required for mouse mammary tumor virus spread within the mammary gland. J. Immunol. 161:2375-2382.
25. Golovkina, T. V., A. B. Jaffe, and S. R. Ross. 1994. Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range. J. Virol. 68:5019-5026.
26. Golovkina, T. V., M. Shlomchik, L. Hannum, and A. Chervonsky. 1999. Organogenic role of B lymphocytes in mucosal immunity. Science 286:1965-1968.
27. Held, W., G. Waanders, A. N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:520-540.
28. Held, W., G. A. Waanders, H. R. MacDonald, and H. Acha Orbea. 1994. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus. Int. Immunol. 6:1403-1407.
29. Karapetian, O., A. N. Shakhov, J. P. Kraehenbuhl, and H. Acha Orbea. 1994. Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model. J. Exp. Med. 180:1511-1516.
30. a-encoded antigens. Immunol. Rev. 107:89-108.
31. a-encoded antigens. Nature 332:40-45.
32. Marrack, P., E. Kushnir, and J. Kappler. 1991. A maternally inherited superantigen encoded by mammary tumor virus. Nature 349:524-526.
33. Muhlbock, O., and A. Dux. 1981. Histocompatability genes and mammary cancer. Elsevier/North-Holland Biomedical Press, Amsterdam, The Netherlands.
34. Nandi, S., M. Handin, A. Robinson, D. R. Pitelka, and L. E. Webber. 1966. Susceptibility of mammary tissues of "genetically resistant" strains of mice to mammary tumor virus. J. Natl. Cancer Inst. 36:783-801.
35. Nandi, S., S. Haslam, and C. Helmich. 1972. Mechanisms of resistance to mammary tumor development in C57BL and I strains of mice. I. Noduligenesis, tumorigenesis, and characteristics of nodules and tumors. J. Natl. Cancer Inst. 48:1005-1012.
36. Nandi, S., and C. M. McGrath. 1973. Mammary neoplasia in mice. Adv. Cancer Res. 17:353-414.
37. Nusse, R. 1988. The int genes in mammary tumorigenesis and in normal development. Trends Genet. 4:291-295.
38. Outzen, H. C., D. Corrow, and L. D. Shultz. 1985. Attenuation of exogenous murine mammary tumor virus in the C3H/HeJ mouse substrain bearing the Lps mutation. JNCI 75:917-923.
39. Pucillo, C., R. Cepeda, and R. J. Hodes. 1993. Expression of a MHC class II transgene determines both superantigenicity and susceptibility to mammary tumor virus infection. J. Exp. Med. 178:1441-1445.
40. Shackleford, G. M., and H. E. Varmus. 1988. Construction of a clonable, infectious and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc. Natl. Acad. Sci. USA 85:9655-9659.
41. Waanders, G. A., A. N. Shakhov, W. Held, O. Karapetian, H. Acha-Orbea, and H. R. MacDonald. 1993. Peripheral T cell activation and deletion induced by transfer of lymphocytes subsets expressing endogenous or exogenous mouse mammary tumor virus. J. Exp. Med. 177:1359-1366.
42. Wrona, T., and J. P. Dudley. 1996. Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus. J. Virol. 70:1246-1249.
43. Yamamoto, K. 1985. Steroid receptor regulated transcription of specific genes and gene networks. Annu. Rev. Genet. 19:209-252.